Global Newborn Screening Market

Global newborn screening market was valued US$ 541.5 Mn in 2017 and is expected to reach US$ 1398.2 Mn by 2026, at a CAGR of 12.59% during a forecast period.Global Newborn Screening Market

For More Information Visit

The newborn screening market is segmented into the products, test type, technology, and region. In terms of products, the global newborn screening market is classified into new-born screening instruments, and new-born screening reagents & assay kits. Based on the test type, the global newborn screening market is divided into the hearing screen test, critical congenital heart disease test, and dry blood spot test. A further technology, global newborn screening market is split hearing screen technology, electrophoresis, tandem mass spectrometry, pulse Oximetry technology, DNA based assays, and enzymes & immunoassay. Based on regions, the global newborn screening market is divided into five main regions are America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The newborn screening market is mainly used for the detection & diagnosis of diseases that mainly occur in infants & newborn babies. Diseases in newborn babies generally include biotinidase deficiency, congenital hypothyroidism, congenital adrenal hyperplasia, congenital toxoplasmosis, cystic fibrosis, and homocystinuria. Screening is done within a few days of birth or before leaving the hospital and in some countries, there is a second screening done at 1-2 weeks of age. In terms of product, the instruments market accounts for the largest share of the global products market, followed by reagents and assay kits. The new-born screening instruments are further sub-segmented into newborn disorder screening, newborn hearing screening, and Pulse Oximetry. The instruments segment is dominating the market owing to the wide usage of newborn screening devices across the globe, the increasing chromosomal abnormalities in infants, growing awareness in urbanized nations and a rising panel of newborn infections. Reagents & assay kits segment is expected to hold major revenue share, owing to increasing number of blood tests life conducted and blood samples stored for future use. Based on test type, dry blood spot test is a major segment and it is majorly used for clinical & pre-clinical pharmacokinetic studies, taking advantage of smaller sampling needs & simplified sample collection & handling. Dry blood spot test testing is a simple method of collecting, shipping and storing blood samples. An increasing prevalence of newborn diseases and technological advancements in newborn screening is fueling growth in the global newborn screening market. Additionally, the growing incidence of fetal health-related abnormalities and government support towards newborn child health is also boosting the market growth. Growing neonatal population base and rising cases of congenital diseases in new-borns is propelling the market growth. Geographically, Asia-Pacific market is anticipated to the fastest-growing region for the newborn screening market owing to the increased birth rate, government programs supporting newborn screening, increasing prevalence of diseases in newborn babies, and increasing prevalence of birth defects. Key players operating in global newborn screening market are AB Sciex, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Covidien PLC, GE Healthcare, Masimo Corporation, Medtronic Inc, Natus Medical Incorporated, PerkinElmer Inc, Trivitron Healthcare, Waters Corporation, and ZenTech S.A.

This Report Is Submitted By @Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.


About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.


Contact info:

Name: Lumawant Godage



Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +91 20 6630 3320/ +919607065656/ +919607195908

Reset Password